Tseng, Ping-TaoPing-TaoTsengZeng, Bing-SyuanBing-SyuanZengHung, Chao-MingChao-MingHungLiang, Chih-SungChih-SungLiangStubbs, BrendonBrendonStubbsCarvalho, Andre FAndre FCarvalhoBrunoni, Andre RAndre RBrunoniSu, Kuan-PinKuan-PinSuYU-KANG TUWu, Yi-ChengYi-ChengWuChen, Tien-YuTien-YuChenLi, Dian-JengDian-JengLiLin, Pao-YenPao-YenLinHsu, Chih-WeiChih-WeiHsuChen, Yen-WenYen-WenChenSuen, Mein-WoeiMein-WoeiSuenSatogami, KazumiKazumiSatogamiTakahashi, ShunShunTakahashiWu, Ching-KuanChing-KuanWuYang, Wei-ChengWei-ChengYangShiue, Yow-LingYow-LingShiueHuang, Tiao-LaiTiao-LaiHuangLi, Cheng-TaCheng-TaLi2023-03-252023-03-252022-08-012168622Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85133491226&doi=10.1001%2fjamapsychiatry.2022.1513&partnerID=40&md5=33867fbf0deb92e155d5ef9ff7733ea4https://scholars.lib.ntu.edu.tw/handle/123456789/629667Negative symptoms have a detrimental impact on functional outcomes and quality of life in people with schizophrenia, and few therapeutic options are considered effective for this symptomatic dimension. Studies have suggested that noninvasive brain stimulation (NIBS) interventions may be effective in treating negative symptoms. However, the comparative efficacy of different NIBS protocols for relieving negative symptoms remains unclear.enjournal article10.1001/jamapsychiatry.2022.1513357315332-s2.0-85133491226https://api.elsevier.com/content/abstract/scopus_id/85133491226